Greenleaf Trust Boosts Stock Position in Colgate-Palmolive (NYSE:CL)

Greenleaf Trust lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 2.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 89,187 shares of the company’s stock after purchasing an additional 2,468 shares during the period. Greenleaf Trust’s holdings in Colgate-Palmolive were worth $6,392,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CL. Parsec Financial Management Inc. raised its stake in Colgate-Palmolive by 0.5% in the second quarter. Parsec Financial Management Inc. now owns 30,081 shares of the company’s stock worth $2,156,000 after buying an additional 146 shares in the last quarter. Tiemann Investment Advisors LLC grew its holdings in shares of Colgate-Palmolive by 2.4% during the first quarter. Tiemann Investment Advisors LLC now owns 6,455 shares of the company’s stock valued at $442,000 after buying an additional 150 shares during the last quarter. Lynch & Associates IN grew its holdings in shares of Colgate-Palmolive by 0.6% during the first quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock valued at $1,983,000 after buying an additional 160 shares during the last quarter. First National Bank of Omaha grew its holdings in shares of Colgate-Palmolive by 1.2% during the first quarter. First National Bank of Omaha now owns 13,499 shares of the company’s stock valued at $925,000 after buying an additional 160 shares during the last quarter. Finally, Griffin Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 0.8% during the first quarter. Griffin Asset Management Inc. now owns 20,357 shares of the company’s stock valued at $1,395,000 after buying an additional 164 shares during the last quarter. Institutional investors own 75.52% of the company’s stock.

A number of research firms have recently commented on CL. Macquarie increased their price target on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, April 29th. Jefferies Financial Group raised their target price on shares of Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. Deutsche Bank raised their target price on shares of Colgate-Palmolive from $74.00 to $76.00 and gave the stock a “hold” rating in a report on Friday, July 12th. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Finally, UBS Group raised their target price on shares of Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $73.13.

In other news, SVP John J. Huston sold 473 shares of Colgate-Palmolive stock in a transaction on Monday, June 17th. The shares were sold at an average price of $72.93, for a total transaction of $34,495.89. Following the transaction, the senior vice president now owns 59,668 shares in the company, valued at approximately $4,351,587.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP John J. Huston sold 14,039 shares of Colgate-Palmolive stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $70.59, for a total transaction of $991,013.01. Following the transaction, the senior vice president now owns 72,101 shares in the company, valued at approximately $5,089,609.59. The disclosure for this sale can be found here. Insiders have sold a total of 422,925 shares of company stock worth $30,478,467 in the last quarter. Corporate insiders own 1.14% of the company’s stock.

Shares of CL stock opened at $71.20 on Friday. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $76.41. The company has a quick ratio of 0.78, a current ratio of 1.13 and a debt-to-equity ratio of 32.25. The stock has a 50 day moving average of $73.13. The stock has a market capitalization of $61.14 billion, a PE ratio of 23.97, a P/E/G ratio of 4.59 and a beta of 0.76.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The company had revenue of $3.87 billion for the quarter, compared to analysts’ expectations of $3.88 billion. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter last year, the company posted $0.77 earnings per share. On average, analysts predict that Colgate-Palmolive will post 2.84 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Thursday, July 18th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. The ex-dividend date of this dividend is Wednesday, July 17th. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: Gap Down Stocks

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.